Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nikos Tsagias"'
Publikováno v:
Cytotherapy. 21:S77
Background & Aim Μonocyte-derived multipotential cells (MOMCs), easily isolated from the peripheral blood, include progenitors capable of differentiating into endothelial lineages in a specific permissive environment and thus represent an autologous
Publikováno v:
Transfusion Medicine. 21:253-261
Background: Umbilical cord (UC) mesenchymal cells have the ability to differentiate into various cell types, which make them an easily obtainable source for therapeutic uses. Different approaches have been used to isolate mesenchymal stem cells (MSC)
Publikováno v:
Transfusion. 51:976-985
BACKGROUND: Placenta is a valuable source of stem cells for cell therapy and future application in the field of regenerative medicine. This is due to the plasticity and the immunomodulatory effects of the stem cells that it contains. In this study we
Autor:
Angelos Daniilidis, George Koliakos, Elena Kostidou, Iro Koliakos, Nikos Tsagias, Kokkona Kouzi-Koliakos, V. Karagiannis
Publikováno v:
Transplantation Proceedings. 41:4340-4344
Introduction Adipose tissue is recognized as an important source of postnatal mesenchymal stem cells for generative medicine applications. Moreover, cord blood stem cells have been shown to contain pluripotent stem cells called unrestricted somatic s
Autor:
Evangelia Michaloudi, V. Karagiannis, Nikos Tsagias, Kokkona Kouzi-Koliakos, Daryoush Hamidi Alamdari, George Koliakos
Publikováno v:
Cytotherapy. 9:654-659
For the application of umbilical cord blood (UCB) units as hematopoietic grafts, a dose of 3.7 x 10(7) nucleated cells (NC)/kg body weight is required. NC can be lost during volume-reduction processing and during thawing. A novel modification of the
Autor:
Nikos, Tsagias, Kokkona, Kouzi-Koliakos, Vasileios, Karagiannis, P, Tsikouras, George G, Koliakos
Publikováno v:
Histology and histopathology. 30(3)
Recently the matrix of umbilical cord began to use as an alternative source of stem cells additionally to the blood of umbilical cord. Umbilical cord has been used mainly for mesenchymal stem cell banking. The immunological characteristics of mesench
Autor:
Nikos Tsagias, Michail Pitiakoudis, Themistoklis Spyridopoulos, George Koliakos, Kokkona-Kouzi Koliakos, Ioanna Korpeti, Eleni Koliakos
Publikováno v:
Cell and tissue banking. 15(3)
Stem cells from human exfoliated deciduous teeth are a population of highly proliferative postnatal stem cells and have been characterized as multipotent stem cells. In this study we developed a fast and sensitive method for stem cells derived from h
Publikováno v:
Reproductive System & Sexual Disorders.
Umbilical cord blood represents an increasingly useful source of hematopoietic stem cells for Bone Marrow Transplantation (BMT), although currently, low cell numbers generally limit its use to pediatric patients. The aim of this study was to evaluate
Publikováno v:
Transfusion. 51(5)
Placenta is a valuable source of stem cells for cell therapy and future application in the field of regenerative medicine. This is due to the plasticity and the immunomodulatory effects of the stem cells that it contains. In this study we present a t
Cell recovery sufficient for adult transplantation by additional cord blood collection from placenta
Autor:
V. Karagiannis, E. Kostidou, D. Hamidi-Alamdari, Nikos Tsagias, Kokkona Kouzi-Koliakos, George Koliakos
Publikováno v:
Transplantation proceedings. 39(10)
The amount of newborn blood that can be collected from a single cord donor is limited, but a significant amount remains in the placenta. We used a simplified perfusion method to collect this additional blood. Umbilical cord blood from 15 newborns was